Drugs
-
acute dystonia, antipsychotics, aripiprazole, dopamine blockade, drug-induced dystonia, Drugs, extrapyramidal symptoms, FAERS, haloperidol, Health Science Reports, medication side effects, metoclopramide, pharmacovigilance, Psychiatry, risperidone, side effectsDrug-Induced Dystonia: Metoclopramide and Antipsychotics Lead FAERS
A 2026 FAERS pharmacovigilance study of 28,938 dystonia reports found the strongest…
-
Drugs, GLP-1 receptor agonists, Psychiatry, semaglutide, SGLT2 inhibitors, Suicidal Ideation, suicidality, suicide, suicide attempt, target trial emulation, type 2 diabetes, veteransSemaglutide Did Not Increase Suicidality in 102,361 Veterans
A 2026 target-trial emulation involving 102,361 U.S. veterans with type 2 diabetes…
-
agranulocytosis, antipsychotics, clozapine, Drugs, early intervention, FDA REMS, Finnish registry, first episode psychosis, negative symptoms, Psychiatry, psychosis, relapse prevention, schizophrenia, treatment-resistant schizophreniaEarly Clozapine in Schizophrenia: 34% Lower Relapse Risk
Clozapine has been the most effective antipsychotic in schizophrenia for almost 40…
-
acute dystonia, antipsychotics, aripiprazole, dopamine partial agonist, Drugs, extrapyramidal symptoms, medication side effects, Neurological Sciences, oculogyric crisis, Psychiatry, side effects, tic disorders, tics, TourettesAripiprazole Oculogyric Crisis in Tourette Tics: 2 Cases at 20-30 mg
A 2026 Neurological Sciences brief communication added 2 Tourette syndrome cases of…
-
ADHD, adverse events, antiseizure medication, Brain, children with epilepsy, Drugs, epilepsy, levetiracetam, neuroscience, oxcarbazepine, pediatric epilepsy, SV2A, therapeutic drug monitoring, topiramateLevetiracetam Range in Children: 2.82-24.37 mcg/mL TDM
A 2026 real-world study involving 1,174 children with epilepsy proposed a levetiracetam…
-
AB10015, ALS, ALS survival, ALSFRS-R, amyotrophic lateral sclerosis, Drugs, ENCALS, masitinib, mast cells, microglia, motor neuron disease, Neurodegenerative Diseases, neuroscience, riluzole, tyrosine kinase inhibitorMasitinib for ALS: AB10015 Reports 42.3% 5-Year Survival
A 2026 AB10015 post-hoc preprint reported 42.3% 5-year survival from amyotrophic lateral…
-
90-day mortality, acute ischemic stroke, antiseizure medications, Brain, Drugs, epilepsy, levetiracetam, Medicare, neuroscience, older adults, post-stroke seizures, poststroke epilepsy, seizure prophylaxis, target trial emulationLevetiracetam After Stroke: 9 Fewer Deaths in Older Adults
A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke…
-
antidepressants, antipsychotics, benzodiazepines, blood screening, clinical toxicology, drug intoxication, Drugs, LC-MS/MS, medication adherence, neuropsychiatric drugs, Psychiatry, serum drug screening77-Drug Blood Screen Found Benzodiazepines in 37.9% of Detections
A 2026 clinical-lab study tested a 77-drug liquid chromatography-tandem mass spectrometry serum…

